Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients

NCT05934487 is registered in ClinicalTrials.gov with Endotronix, Inc. as lead sponsor.

NCT NCT05934487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05934487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
Lead sponsor
Endotronix, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 29, 2023
Completion date
September 30, 2033
Enrollment
1,750 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure nyha class ii, heart failure nyha class iii